Molecular Diagnosis & Therapy

Papers
(The median citation count of Molecular Diagnosis & Therapy is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker127
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects85
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors71
Clinical Exome Reanalysis: Current Practice and Beyond56
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date55
A Window of Opportunity for Newborn Screening46
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”46
Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer43
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate41
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target38
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors38
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights33
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?31
Piflufolastat F 18: Diagnostic First Approval31
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach30
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma30
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk26
Advances and Challenges in the Diagnosis of Leishmaniasis24
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics24
Personalizing Oncolytic Immunovirotherapy Approaches24
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges23
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease23
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders22
Transcript-Based Diagnosis and Expanded Phenotype of an Intronic Mutation in TPM3 Myopathy21
Afamitresgene Autoleucel: First Approval21
Comment on “The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis”20
Smart PROTACs Enable Controllable Protein Degradation for Precision Cancer Therapy18
MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review18
Diagnosis of Lung Cancer Through Exhaled Breath: A Comprehensive Study18
Development of a New Rapid Simultaneous Molecular Assay for the Detection of STI Pathogens and Drug Resistance-Associated Mutations17
Molecular Therapeutics in Development to Treat Alzheimer’s Disease17
Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy17
Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort16
Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review16
Molecular Dynamics as a Precision Therapy: A Perspective on Epileptic Encephalopathies15
The Road Traveled and Journey Ahead for the Genetics and Genomics of Tinnitus15
Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer15
Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants15
In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia14
The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis14
Achromatopsia: Genetics and Gene Therapy14
Is the Homologous Recombination Repair Mutation Defined by a 15-Gene Panel Associated with the Prognosis of Epithelial Ovarian Cancer?13
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients13
Preimplantation Genetic Testing for Monogenic Conditions: Is Cell-Free DNA Testing the Next Step?13
Lifileucel: First Approval13
Correction to: Molecular Therapeutics in Development to Treat Alzheimer’s Disease13
Celomic Fluid: Laboratory Workflow for Prenatal Diagnosis of Monogenic Diseases12
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation12
Correction: Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders12
Role of lncRNAs in Remodeling of the Coronary Artery Plaques in Patients with Atherosclerosis12
Correction to: Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus11
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings11
Correction to: Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-211
The Role οf Ion Channels in the Development and Progression of Prostate Cancer11
Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”11
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of R10
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma10
Emerging RNAi Therapies to Treat Hypertension10
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab10
Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models10
Fluorescence Imaging-Assessed Surgical Margin Detection in Head and Neck Oncology by Passive and Active Targeting10
Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma10
Blood Biomarkers of Long COVID: A Systematic Review9
Inner Ear Gene Therapy: An Overview from Bench to Bedside9
Obecabtagene Autoleucel: First Approval9
Author reply to Wang et al.: “The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta‑analysis”9
Future Prospects for Epigenetics in Autism Spectrum Disorder9
Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date8
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance8
Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features8
Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review8
EasyNAT MP Assay: A Simple, Rapid, and Low-Cost Method to Detect Mycoplasma pneumoniae Using Cross-Priming Amplification Technology8
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis8
Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC7
Internal Standardization of the Interpretation and Reporting of Sequence Variants in Hematologic Neoplasms7
Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma7
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment7
Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave7
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience7
The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy7
Exploring the Role of HtrA Family Genes in Cancer: A Systematic Review7
Metastasis Prevention: Focus on Metastatic Circulating Tumor Cells7
Zevorcabtagene Autoleucel: First Approval7
Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experi7
The Role of [18F]F-FDG PET/CT for Predicting Histology and Prognosis in Patients with Thymic Lesions7
Evaluation of the Suitability of RNAscope as a Technique to Measure Gene Expression in Clinical Diagnostics: A Systematic Review7
Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis7
Nanocarrier-Mediated Delivery of MicroRNAs for Fibrotic Diseases7
Molecular Diagnosis of Primary Cardiomyopathy in 231 Unrelated Pediatric Cases by Panel-Based Next-Generation Sequencing: A Major Focus on Five Carriers of Biallelic TNNI3 Pathogenic Variants7
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics6
Development and Evaluation of a Droplet Digital PCR Assay for 8p23 β-Defensin Cluster Copy Number Determination6
Tumour Marker Expression in Head and Neck Malignancies to Identify Potential Targets for Intraoperative Molecular Near-Infrared Imaging6
SARS-CoV-2 Testing Strategies in the Diagnosis and Management of COVID-19 Patients in Low-Income Countries: A Scoping Review6
Characterization of 13 Novel Genetic Variants in Genes Associated with Epilepsy: Implications for Targeted Therapeutic Strategies6
Optimization of a Quantitative PCR Methodology for Detection of Aspergillus spp. and Rhizopus arrhizus6
Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital6
‘Longing’ for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing6
Evaluation of Factors that Affect the Performance of COVID-19 Molecular Assays Including Presence of Symptoms, Number of Detected Genes and RNA Extraction Type6
Long-Read Nanopore Sequencing of RPGR ORF15 is Enhanced Following DNase I Treatment of MinION Flow Cells6
Functional Association of miR-133b and miR-21 Through Novel Gene Targets ATG5, LRP6 and SGPP1 in Coronary Artery Disease6
Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer6
Elivaldogene Autotemcel: First Approval6
Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms5
Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery5
Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?5
Advancing Rabies Diagnosis: Time for a New “Gold Standard”?5
Is There a Role for FAPI PET in Urological Cancers?5
A miRNA-Based Approach in Autosomal Dominant Polycystic Kidney Disease: Challenges and Insights from Adult to Pediatric Evidence5
Recent Insights on Genetic Testing in Primary Prostate Cancer5
Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview5
Gestational Diabetes is Associated with an Increased Expression of miR-27a in Peripheral Blood Mononuclear Cells5
Proteomic Alterations in Salivary Exosomes Derived from Human Papillomavirus-Driven Oropharyngeal Cancer5
The Future of CAR T Therapeutics to Treat Autoimmune Disorders5
Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors5
Hepatic Clearance of Cell-Free DNA: Possible Impact on Early Metastasis Diagnosis5
Cell-Free DNA: Features and Attributes Shaping the Next Frontier in Liquid Biopsy4
Biomarker Determinants of Early Anthracycline-Induced Left Ventricular Dysfunction in Breast Cancer: A Systematic Review and Meta-Analysis4
Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP4
Multicenter Performance Evaluation of the Revogene® GBS DS Real-Time PCR Assay for Group B Streptococcus Detection During Labor4
Clinical Validation of a Targeted RNA-Sequencing Assay for Driver Gene Alteration Detection in Non-Small Cell Lung Cancer4
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy4
MicroRNA-146a Signature in Psoriasis: A Systematic Review and Meta-Analysis4
Modern Biomarkers for Autism Spectrum Disorder: Future Directions4
Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option4
Single-Cell Sequencing in Neurodegenerative Disorders4
Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta-Analysis4
Tracking the Plasma C-Terminal Agrin Fragment as a Biomarker of Neuromuscular Decline in 18- to 87-Year-Old Men4
Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers4
Multicenter In-House Evaluation of an Amplicon-Based Next−Generation Sequencing Panel for Comprehensive Molecular Profiling4
0.12514996528625